| Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies MJ Gomes, S Martins, D Ferreira, MA Segundo, S Reis International Journal of Nanomedicine 9 (1), 1231-1242, 2014 | 167 | 2014 |
| Thiolation and cell-penetrating peptide surface functionalization of porous silicon nanoparticles for oral delivery of insulin N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, ... Advanced Functional Materials 26 (20), 3405-3416, 2016 | 107 | 2016 |
| Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy C Martins, F Araújo, MJ Gomes, C Fernandes, R Nunes, W Li, HA Santos, ... European Journal of Pharmaceutics and Biopharmaceutics 138, 111-124, 2019 | 83 | 2019 |
| Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system MJ Gomes, J das Neves, B Sarmento International Journal of Nanomedicine 9 (1), 1757-1769, 2014 | 80 | 2014 |
| In vivo dual-delivery of glucagon like peptide -1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy F Araújo, N Shrestha, MJ Gomes, B Herranz-Blanco, D Liu, JJ Hirvonen, ... Nanoscale 8 (20), 10706-10713, 2016 | 73 | 2016 |
| Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at blood-brain barrier MJ Gomes, PJ Kennedy, S Martins, B Sarmento Nanomedicine (London) 12 (12), 2017 | 67 | 2017 |
| Tailoring lipid and polymeric nanoparticles as siRNA carriers towards the blood-brain barrier – from targeting to safe administration MJ Gomes, C Fernandes, S Martins, F Borges, B Sarmento Journal of Neuroimmune Pharmacology 12 (1), 107-119, 2017 | 62 | 2017 |
| siRNA as a tool to improve the treatment of brain diseases: mechanism, targets and delivery MJ Gomes, S Martins, B Sarmento Ageing Research Reviews 21, 43-54, 2015 | 60 | 2015 |
| Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, M Airavaara, ... Journal of Controlled Release 232, 113-119, 2016 | 58 | 2016 |
| Development of a PEGylated-based platform for efficient delivery of dietary antioxidants across the blood–brain barrier C Fernandes, M Pinto, C Martins, MJ Gomes, B Sarmento, PJ Oliveira, ... Bioconjugate Chemistry 29 (5), 1677-1689, 2018 | 37 | 2018 |
| Cell-based in vitro models for studying blood-brain barrier (BBB) permeability MJ Gomes, B Mendes, S Martins, B Sarmento Concepts and models for drug permeability studies: cell and tissue based in …, 2016 | 26 | 2016 |
| A new approach for a blood-brain barrier model based on phospholipid vesicles: membrane development and siRNA-loaded nanoparticles permeability MJ Gomes, J Dreier, J Brewer, S Martins, M Brandl, B Sarmento Journal of Membrane Science 503, 8-15, 2016 | 18 | 2016 |
| Nanoparticle functionalization for brain targeting drug delivery and diagnostic MJ Gomes, B Mendes, S Martins, B Sarmento Handbook of nanoparticles: synthesis, functionalization and surface …, 2016 | 7 | 2016 |
| Lipid nanoparticles for topical and transdermal application for alopecia treatment MJ Gomes Faculty of Engineering, University of Porto, Portugal, 2013 | 3 | 2013 |
| Modulation of drug efflux at the blood-brain barrier through targeted siRNA delivery via nanoparticles MJBT Gomes PQDT-Global, 2017 | | 2017 |
| Multifunctional tailorable composite system as a dual peptide-drug delivery system F Araújo, N Shrestha, MJ Gomes, D Liu, B Herranz-Blanco, J Hirvonen, ... | | |
| Nanoparticles developed as siRNA carriers towards the blood-brain barrier: from targeting to safe administration MJ Gomes, C Fernandes, S Martins, F Borges, B Sarmento | | |
Bruno Sarmentoi3S - University of PortoVerified email at ineb.up.pt
